Investments
105 Investments in 57 Companies
Exits
9 IPOs & 7 Acquisitions
Founders:
Edwin Kania
Headquarters:
Cambridge, MA
Funds Raised:
Undisclosed
Description:
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabs(TM)
Website:
http://www.flagshipventures.com

Investor Details

Update
Founded:
2000
Type:
Venture Capital that does Early Stage Venture, Later Stage Venture, Private Equity, and Debt Financing Investments
Sectors:
Biotechnology, Health Care, Software
Regions:
United States

Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabs(TM) which invents and launches transformative companies, and Venture Capital, which finances and realizes innovative, early-stage companies. Founded in 2000, and based in Cambridge, Massachusetts, Flagship Ventures manages over $900 million in capital. The Flagship team innovates and invests in three principal business sectors: therapeutics, health technologies and sustainability/clean technology. Past successful Flagship portfolio ventures include: Adnexus (acquired by Bristol-Myers Squibb), Accuri Cytometers (acquired by Becton, Dickinson), Morphotek (acquired by Eisai), Color Kinetics (acquired by Philips), AVEO (NASDAQ: AVEO) and BG Medicine (NASDAQ: BGMD). Recent notable portfolio ventures include: Joule Unlimited, Agios, Affinnova, AeroDesigns and Novomer. For more information, please visit www.flagshipventures.com.

Current Team (30)

Update

Past Team (15)

Update

Investments (105)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    One Memorial Drive

    7th Floor

    Cambridge, MA 02142

    USA